We do not diagnose disease or recommend a dietary supplement for the treatment of disease. You should share this information with your physician who can determine what nutrition, disease and injury treatment regimen is best for you. You can search this site or the web for topics of interest that I may have written (use Dr Simone and topic).
“We provide truthful information without emotion or influence from the medical establishment, pharmaceutical industry, national organizations, special interest groups or government agencies.” Charles B Simone, M.MS., M.D.
HYDROXYCHLOROQUINE SAVES LIVES
Lawrenceville, NJ (Charles Simone, M.MS., M.D.) – The Henry Ford COVID-19 Task Force clinicians at the Henry Ford Health System in Detroit, Michigan did an observational study from a single institution involving 2,541 patients and published their findings in the International Journal of Infectious Diseases (accepted date June 29, 2020) entitled, Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19. https://www.ijidonline.com/action/showPdf?pii=S1201-9712%2820%2930534-8 (journal pre-proof). The Henry Ford Health System is composed of six large hospitals, the largest is an 802-bed quaternary academic teaching hospital in urban Detroit. Consecutive patients hospitalized with a COVID-related admission in the health system from March 10, 2020 to May 2, 2020 were included.
Their Conclusion: “According to a protocol-based treatment algorithm, among hospitalized patients, use of hydroxychloroquine alone and in combination with azithromycin was associated with a significant reduction in-hospital mortality compared to not receiving hydroxychloroquine.” Steroids were also used.
Hydroxychloroquine and Ivermectin are lysosomotropic agents that should be used within the first five days of exposure to SARS-CoV 2 (COVID-19). These medicines cross the lysosomal membrane and become protonated thus increasing the lysosome’s pH (alkaline) rendering the lysosome nonfunctional. These medicines include Hydroxychloroquine and Ivermectin.
Hydroxychloroquine – 400 mg twice daily for 2 doses on day 1, followed by 200 mg twice daily on days 2-5.
Azithromycin – 500 mg once daily on day 1 followed by 250 mg once daily for the next 4 days. The combination of hydroxychloroquine+azithromycin was reserved for selected patients with severe COVID-19 and with minimal cardiac risk factors.
An electrocardiogram QTc>500ms constituted an elevated cardiac risk and consequently hydroxychloroquine was reserved for patients with severe disease with telemetry monitoring and serial QTc checks.
Jan 28, 2021 – FACEBOOK and AMERICAN JOURNAL OF MEDICINE admit their position on hydroxychloroquine was wrong.
Early use of hydroxychloquine had a 79% lower mortality rate in countries that allowed the use of the safe drug.
A new study in the American Journal of medicine in January showed a much lower mortality rate for patients with COVID-19 being treated with hydroxychloroquine while still at home. Also today the Facebook Oversight Board said it overturned its previous case on the effectiveness of HCQ.
The following is provided by HCQMETA.com
Think of all the doctors, politicians, federal agencies, media, big tech that have told you that hydroxychloroquine was dangerous and not to be used.
Think of how many lives could have been saved.